Thus, in addition to the potent inhibition seen in cell culture models and in vitro kinase assays, PF-06463922 exhibits robust activity towards tumor growth in a transgenic ALK-driven mouse model of neuroblastoma. The gene discussed is ALK; the disease is neoplasm.